Renewable Energy Co.s Getting More Investment Cash than Oil Co.s
In 2008 Green energy companies received more investment funding than fossil fuel companies as per a report from the United Nations.
Reasons Why Private Companies Stay Private for Easier Financing
Private company financing is in many ways easier to get as you don’t have the regulatory hurdles you would as a publicly traded company on a stock exchange. The most important reason why some companies stay private instead of going public though is being able to keep control of the business, making decisions which generally are best for the long term success of the organization.
Succession Planning Best Way to Get Top Dollar for your Business
Growing up in a small business environment, watching your parents work harder and harder to make a good life for us as children I believe that my parents probably worked too hard and didn’t give themselves the opportunity to maximize the value of their businesses before retiring.
Succession planning should start earlier, not at age 65 [...]
5 Big Business Valuation Myths
Myth 1: The value of my business can be generally determined by using an earnings multiplier of my industry. ie. 3 times EBITDA
This is the most common myth. The earnings multiplier can be useful to get an overall general value based on the industry, but it doesn’t apply to all businesses within the [...]
Most Overlooked Issue in a Purchase/Sale of a Private Company Business
In the sale or purchase of a private company its still necessary to use best practices in order to have the parties feel good about the transaction. Using the services of a corporate financial advisor, a tax accountant, a corporate lawyer who work together as a team from the beginning will provide you with the [...]
Xenon Pharmaceuticals CEO Interview on Canada’s Reduced Funding Part 2
Part 2: Simon Pimstone, President & CEO of Xenon Pharmaceuticals Interview
As a large part of the life sciences group in BC Simon Pimstone met with Liberal leader Michael Ignatieff on life sciences and explained the issues of funding, and you would think that it would fit in with Ignatieff’s desire to build a larger knowledge [...]
Xenon Pharmaceuticals CEO Interview on Canadian Funding Decreases Part 1
Part 1: Simon Pimstone, President & CEO of Xenon Pharmaceuticals Interview
Canadian government’s announcement on reduction of future funding for Genome Canada affects life sciences companies in British Columbia, including larger start ups such as Xenon Pharmaceuticals.
Affects of this including having fewer jobs and hindering the ability of companies to commercialize their intellectual property they have [...]
Cardiome Pharma Shares Skyrocket on $700 Million Deal with Merck
Vancouver, B.C. based Cardiome Pharma shares skyrocket on a $700 million licensing agreement with Merck based out of Whitestation, New Jersey for Vernakalant, an investigational drug for treatment of atrial ibrillation. The agreement provides Merck with exclusive global rights to the oral formulation of vernakalant (vernakalant [oral]) for maintaining of normal heart rhythm in patients [...]
Polaroid Auctioned Off to Patriarch Partners with $59.1 Milln bid
Polaroid known as a maker of instant cameras and film was finally auctioned off for $59.1 million in a bankrupty protection. This famous company had come upon hard times, but it’s interesting to note that the price tag was for the intellectual property, company, and digital and hard film collection.
Question is that does Patriarch think [...]
Short Update: Life Sciences Funding For March 09
Short updates on Life Sciences funding for March 2009.
BiOptix Diagnostics, Inc.: Series A $3M
BiOptix (Boulder, CO) a commercial focused developer of an array-based biomolecule detection system that addresses many markets that currently cannot obtain the needed sensitivity and throughput in a single solution, closed a $3M Series A finacing.
NeoVista, Inc.: [...]
